2025年度，业绩扭亏的主要原因为：在全球农化市场需求回升的背景下，公司积极拓展市场及新增产能 逐步释放，主要产品产销规模增长，部分产品销售价格有所回升，营收水平及毛利率均同比上涨。 苏利股份（603585）(603585.SH)发布2025年年度业绩预告，预计2025年年度实现归属于上市公司股东 的净利润1.9亿元至2.2亿元，与上年同期(法定披露数据)相比，将实现扭亏为盈。 ...

Core Viewpoint - Su Li Co., Ltd. (603585.SH) is expected to achieve a net profit attributable to shareholders of 190 million to 220 million yuan in 2025, marking a turnaround from loss to profit compared to the previous year [1] Financial Performance - The estimated net profit excluding non-recurring gains and losses for 2025 is projected to be between 184.685 million and 214.685 million yuan [1] - The main reason for the turnaround in performance is the recovery in global agrochemical market demand, alongside the company's active market expansion and gradual release of new production capacity [1] Market Dynamics - The growth in sales volume of major products and a rebound in sales prices have contributed to the increase in revenue and gross margin year-on-year [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002513 证券简称：蓝丰生化 公告编号：2026-006 江苏蓝丰生物化工股份有限公司 2025年度业绩预告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记载、误导性陈述或者重大遗 漏。 一、本期业绩预计情况 1、业绩预告期间：2025年1月1日至2025年12月31日。 2、业绩预告情况：预计净利润为负值。 ■ 二、与会计师事务所沟通情况 本次业绩预告相关数据是公司初步测算的结果。公司与年审会计师事务所就业绩预告有关事项进行了预 沟通，双方不存在重大分歧，具体数据以审计结果为准。 三、业绩变动原因说明 1、公司及子公司对报告期末各类资产进行全面清查，基于谨慎性原则，公司对存在减值迹象的相关资 产计提了资产减值准备，包括预计信用减值损失、资产减值损失，合计减少本期归属上市公司股东净利 润约6,416.22万元。 2、报告期内，受部分原材料价格大幅上涨而公司主要产品销售价格持续下降的综合影响，公司农化板 块亏损持续；新能源板块尽管通过技术升级降低了生产成本，但受行业竞争的影响，产品价格仍在低位 运行，虽然同比亏损幅度有较大幅度下降 ...

1月26日晚，先达股份发布2025年度业绩预告，预计全年实现净利润1.35亿元至1.55亿元，上年同期该指 标为亏损2587.55万元，实现同比扭亏为盈。 近期农化行业多家公司业绩大幅预喜。记者梳理发现，目前已有20家农化上市公司披露业绩预告，其中 10家业绩预增、2家扭亏。 多家农化上市公司业绩预增 对于业绩预增的原因，先达股份表示，核心系公司主要产品烯草酮销售价格较上年同期显著上涨，推动 公司产品毛利率整体提升；本年度创制产品吡唑喹草酯系列成功上市并实现销售，进一步带动国内制剂 产品毛利率增长。 与此同时，公司持续推进运营改革，实施毛利分配方案，强化成本费用管控，整体运行效率不断提高。 不止先达股份，农药化工板块多家企业均2025年业绩高增。草铵膦头部企业利尔化学于1月23日发布 2025年度业绩快报。报告期内，公司实现营业收入约90.08亿元，同比增加23.21%；归母净利润约4.79 亿元，同比增加122.33%。 对于这一成绩，利尔化学称，2025年行业虽然依旧面临激烈市场竞争，但公司凭借部分产品需求增长， 综合毛利率同比有所上涨以及降本增效取得成效，最终带动业绩同比上涨。 1月22日，利民股份发布 ...

Core Viewpoint - The agricultural chemical industry is experiencing significant growth, with multiple companies reporting substantial increases in earnings for the year 2025, driven by rising product prices and improved operational efficiencies [1][2][3]. Group 1: Company Performance - Xinda Co. expects a net profit of 135 million to 155 million yuan for 2025, a turnaround from a loss of 25.87 million yuan in the previous year [1]. - Lier Chemical reported an estimated revenue of approximately 9.008 billion yuan for 2025, a year-on-year increase of 23.21%, with a net profit of about 479 million yuan, up 122.33% [2]. - Limin Co. anticipates a net profit of 465 million to 500 million yuan for 2025, representing a year-on-year growth of 471.55% to 514.57% [2]. - Dongfang Tieta expects a net profit of 1.08 billion to 1.27 billion yuan for 2025, reflecting a growth of 91.40% to 125.07% compared to the previous year [3]. Group 2: Industry Trends - The agricultural chemical sector is seeing a positive trend, with 20 listed companies having disclosed earnings forecasts, of which 10 are expected to see profit increases and 2 are expected to turn losses into profits [1]. - The recent policy changes regarding export tax rebates for agricultural chemicals are anticipated to boost industry sentiment, as companies may increase prices to maintain profitability amid rising export costs [4][5]. - The cancellation of export tax rebates is expected to lead to higher costs for exporters, prompting them to raise prices, which could support both volume and price increases in the agricultural chemical market [5].

Core Viewpoint - Bluefeng Biochemical (002513.SZ) expects a net profit loss attributable to shareholders of the listed company between 230 million and 150 million yuan for the year 2025, with a similar range for net profit after deducting non-recurring gains and losses [1] Group 1: Performance Forecast - The company anticipates a net profit loss of 230 million to 150 million yuan for the year 2025 [1] - The expected loss after deducting non-recurring gains and losses is also projected to be between 230 million and 150 million yuan [1] Group 2: Reasons for Performance Changes - The company and its subsidiaries conducted a comprehensive review of various assets at the end of the reporting period, leading to the recognition of asset impairment provisions due to signs of impairment, which reduced the net profit attributable to shareholders by approximately 64.16 million yuan [1] - The agricultural chemical segment continues to incur losses due to a significant increase in raw material prices while the sales prices of main products have been declining [1] - Although the new energy segment has reduced production costs through technological upgrades, it still faces low product prices due to industry competition, resulting in a significant decrease in the loss margin year-on-year, but the profitability has not met expectations [1]

Group 1 - The company, Bluefeng Biochemical, expects a net loss attributable to shareholders of 150 million to 230 million yuan for 2025, with basic earnings per share loss ranging from 0.61 yuan to 0.40 yuan [1] - In the same period last year, the company reported a net loss of approximately 253 million yuan, with basic earnings per share loss of 0.68 yuan [1] - The primary reason for the performance change is a comprehensive review of various assets, leading to asset impairment provisions totaling approximately 64.16 million yuan, which reduced the net profit attributable to shareholders for the current period [1] Group 2 - The agricultural chemical segment continues to incur losses due to a significant increase in raw material prices while the sales prices of main products have been declining [1] - The new energy segment has managed to reduce production costs through technological upgrades, but product prices remain low due to industry competition, resulting in a significant decrease in the loss margin year-on-year, although profitability has not met expectations [1]

蓝丰生化公告称，2025年1月1日至12月31日，公司预计归属于上市公司股东的净利润亏损1.5亿-2.3亿 元，上年同期亏损2.53亿元；扣非净利润亏损1.5亿-2.3亿元，上年同期亏损2.32亿元；基本每股收益亏 损0.61元/股-0.40元/股，上年同期亏损0.68元/股。业绩变动主要因计提资产减值准备及农化、新能源板 块表现不佳，盈利未达预期。 ...

Investment Rating - The report suggests a positive outlook for the basic chemical industry, particularly due to rising oil prices and improving product demand [3][5]. Core Insights - The report highlights that the continuous rise in crude oil prices, driven by geopolitical tensions and OPEC+ decisions, is expected to support the recovery of the refining sector [3][5]. - PTA and polyester filament prices are on the rise, with PTA industry measures contributing to improved market conditions [4][5]. - The report emphasizes the potential growth of bio-jet fuel (SAF) as a renewable energy source, recommending attention to companies like Zhuoyue New Energy [5]. Summary by Sections 1. Industry and Product Tracking - Crude oil prices have increased, with WTI at $61.29 per barrel and Brent at $66.23 per barrel, reflecting a week-on-week rise of 3.11% and 3.16% respectively [3]. - PTA prices have risen to 5140 CNY per ton, with polyester filament prices also increasing, indicating a recovery in the market [4][10]. 2. Key Chemical Product Price Tracking - Key products such as nicotinamide (up 8.96%), acetonitrile (up 8.72%), and styrene (up 7.96%) have shown significant price increases, while industrial-grade dimethyl carbonate and epoxy propane have seen declines [10]. - The report notes that the price of glyphosate has risen to 23296 CNY per ton, with a weekly increase of 200 CNY per ton [15]. 3. Refining Sector - The refining sector is expected to benefit from stable oil prices and increased demand, with companies like Hengli Petrochemical and Satellite Chemical recommended for investment [5]. 4. Agricultural Chemicals - The prices of ammonium phosphate and potassium chloride have increased, with ammonium phosphate priced at 3821 CNY per ton [17][20]. 5. Fluorochemicals - Prices for refrigerants R22 and R125 have risen, supported by supply constraints and environmental regulations [22][24].

Group 1 - A-shares continue to rise with increased trading volume, breaking previous highs, driven by heightened risk appetite during the spring rally [1] - Huatai Securities suggests that while strong momentum may allow for further spring market space, the trading structure is concentrated, indicating a potential shift towards rotation as some hot sectors may need to digest pressure [1] - The upcoming earnings forecast window suggests focusing on high-cost performance sectors, particularly those benefiting from external demand chain improvements and lower crowding themes, such as gaming, duty-free, batteries, engineering machinery, and agricultural chemicals [1] Group 2 - Non-ferrous metals are becoming a key focus for institutional investment, with seven non-ferrous metal-themed funds reported in the past week and significant net subscriptions exceeding 51 billion yuan for non-gold ETFs over the past year [3] - The pig farming industry is expected to see a slight recovery in sow production capacity in 2024, leading to a downward trend in pig prices in 2025, although there may still be slight profits throughout the year [3] - The industry is undergoing structural changes due to "anti-involution," with both passive and active capacity reductions expected to drive a gradual recovery in pig prices by the second half of 2026 [3] Group 3 - The industry is expected to remain in a trend of reduced demand and structural adjustment through 2026, with limited improvements in supply, demand, and profitability [5] - Focus on two main lines: differentiated production control and the potential recovery of undervalued cash flow assets, as well as the acceleration of domestic substitution in high-end steel materials benefiting leading special steel companies [5] - Southbound capital saw a record net inflow of 140.48 billion Hong Kong dollars, continuing to increase positions in the Hong Kong stock market, contributing to a strong performance in the Hang Seng Index and technology index [5] Group 4 - The short-term market trend is strong with significant new capital entering, although the market's profit-making effect remains weak [7] - The Shanghai Composite Index shows a one-sided upward trend, contrasting with regulatory "cooling" strategies, indicating potential downward pressure on the index [10] - The A-share earnings cycle may have reached a turning point, with a gradual improvement in earnings expected, making the recovery elasticity of earnings a key focus for 2026 [10]